March 7, 2018 / 3:18 PM / 5 months ago

BRIEF-Merck KGaA Announces Positive Phase IIb Results For Evobrutinib In Relapsing Multiple Sclerosis

March 7 (Reuters) - Merck KGaA:

* MERCK KGAA, DARMSTADT, GERMANY, ANNOUNCES POSITIVE PHASE IIB RESULTS FOR EVOBRUTINIB IN RELAPSING MULTIPLE SCLEROSIS

* MERCK KGAA - STUDY HAS MET ITS PRIMARY ENDPOINT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below